nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP1A1—Methoxsalen—hematologic cancer	0.0429	0.0624	CbGbCtD
Granisetron—CYP1A1—Bortezomib—hematologic cancer	0.0408	0.0594	CbGbCtD
Granisetron—CYP1A1—Daunorubicin—hematologic cancer	0.039	0.0568	CbGbCtD
Granisetron—CYP1A1—Thalidomide—hematologic cancer	0.0355	0.0517	CbGbCtD
Granisetron—CYP1A1—Dacarbazine—hematologic cancer	0.0306	0.0445	CbGbCtD
Granisetron—CYP1A1—Dasatinib—hematologic cancer	0.024	0.0349	CbGbCtD
Granisetron—CYP3A5—Daunorubicin—hematologic cancer	0.0234	0.0341	CbGbCtD
Granisetron—CYP2D6—Lomustine—hematologic cancer	0.0228	0.0331	CbGbCtD
Granisetron—CYP3A5—Thalidomide—hematologic cancer	0.0213	0.031	CbGbCtD
Granisetron—CYP3A5—Teniposide—hematologic cancer	0.0204	0.0296	CbGbCtD
Granisetron—CYP2D6—Idarubicin—hematologic cancer	0.0203	0.0295	CbGbCtD
Granisetron—CYP3A5—Ifosfamide—hematologic cancer	0.0188	0.0273	CbGbCtD
Granisetron—CYP3A5—Imatinib—hematologic cancer	0.0179	0.0261	CbGbCtD
Granisetron—CYP2D6—Hydroxyurea—hematologic cancer	0.0173	0.0251	CbGbCtD
Granisetron—CYP3A4—Bexarotene—hematologic cancer	0.0156	0.0227	CbGbCtD
Granisetron—CYP2D6—Bortezomib—hematologic cancer	0.015	0.0219	CbGbCtD
Granisetron—CYP3A4—Busulfan—hematologic cancer	0.0145	0.0211	CbGbCtD
Granisetron—CYP3A4—Lomustine—hematologic cancer	0.0145	0.0211	CbGbCtD
Granisetron—CYP3A5—Dasatinib—hematologic cancer	0.0144	0.021	CbGbCtD
Granisetron—CYP3A4—Thiotepa—hematologic cancer	0.0129	0.0188	CbGbCtD
Granisetron—CYP1A1—Dexamethasone—hematologic cancer	0.0123	0.0179	CbGbCtD
Granisetron—CYP3A5—Irinotecan—hematologic cancer	0.0112	0.0163	CbGbCtD
Granisetron—CYP2D6—Imatinib—hematologic cancer	0.011	0.016	CbGbCtD
Granisetron—CYP3A4—Methoxsalen—hematologic cancer	0.01	0.0146	CbGbCtD
Granisetron—CYP2D6—Nilotinib—hematologic cancer	0.01	0.0145	CbGbCtD
Granisetron—CYP2D6—Vinorelbine—hematologic cancer	0.00992	0.0144	CbGbCtD
Granisetron—CYP3A5—Vincristine—hematologic cancer	0.0098	0.0143	CbGbCtD
Granisetron—CYP3A4—Bortezomib—hematologic cancer	0.00955	0.0139	CbGbCtD
Granisetron—CYP3A4—Daunorubicin—hematologic cancer	0.00913	0.0133	CbGbCtD
Granisetron—CYP3A5—Etoposide—hematologic cancer	0.00898	0.0131	CbGbCtD
Granisetron—CYP3A4—Cytarabine—hematologic cancer	0.00806	0.0117	CbGbCtD
Granisetron—CYP3A4—Teniposide—hematologic cancer	0.00794	0.0115	CbGbCtD
Granisetron—CYP3A5—Dexamethasone—hematologic cancer	0.00738	0.0107	CbGbCtD
Granisetron—CYP3A4—Ifosfamide—hematologic cancer	0.00732	0.0107	CbGbCtD
Granisetron—CYP3A4—Imatinib—hematologic cancer	0.007	0.0102	CbGbCtD
Granisetron—CYP3A4—Ruxolitinib—hematologic cancer	0.00659	0.00959	CbGbCtD
Granisetron—CYP3A4—Nilotinib—hematologic cancer	0.00636	0.00925	CbGbCtD
Granisetron—CYP3A4—Vinorelbine—hematologic cancer	0.00631	0.00917	CbGbCtD
Granisetron—CYP2D6—Vinblastine—hematologic cancer	0.00611	0.00889	CbGbCtD
Granisetron—CYP3A4—Triamcinolone—hematologic cancer	0.00577	0.00839	CbGbCtD
Granisetron—CYP3A4—Dasatinib—hematologic cancer	0.00562	0.00818	CbGbCtD
Granisetron—CYP3A4—Mitoxantrone—hematologic cancer	0.00555	0.00808	CbGbCtD
Granisetron—CYP3A4—Betamethasone—hematologic cancer	0.00495	0.0072	CbGbCtD
Granisetron—CYP3A4—Prednisolone—hematologic cancer	0.00488	0.0071	CbGbCtD
Granisetron—CYP3A4—Prednisone—hematologic cancer	0.00461	0.00671	CbGbCtD
Granisetron—CYP2D6—Dexamethasone—hematologic cancer	0.00453	0.00658	CbGbCtD
Granisetron—CYP3A4—Irinotecan—hematologic cancer	0.00437	0.00636	CbGbCtD
Granisetron—CYP3A4—Vinblastine—hematologic cancer	0.00389	0.00565	CbGbCtD
Granisetron—CYP3A4—Vincristine—hematologic cancer	0.00382	0.00556	CbGbCtD
Granisetron—CYP2D6—Doxorubicin—hematologic cancer	0.00375	0.00546	CbGbCtD
Granisetron—CYP3A4—Etoposide—hematologic cancer	0.0035	0.00509	CbGbCtD
Granisetron—CYP3A4—Dexamethasone—hematologic cancer	0.00288	0.00419	CbGbCtD
Granisetron—CYP3A4—Doxorubicin—hematologic cancer	0.00239	0.00347	CbGbCtD
Granisetron—Infection—Prednisone—hematologic cancer	3.82e-05	0.000137	CcSEcCtD
Granisetron—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.81e-05	0.000137	CcSEcCtD
Granisetron—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.81e-05	0.000137	CcSEcCtD
Granisetron—Chills—Epirubicin—hematologic cancer	3.8e-05	0.000136	CcSEcCtD
Granisetron—Pruritus—Etoposide—hematologic cancer	3.79e-05	0.000136	CcSEcCtD
Granisetron—Shock—Prednisone—hematologic cancer	3.78e-05	0.000136	CcSEcCtD
Granisetron—Arrhythmia—Epirubicin—hematologic cancer	3.78e-05	0.000136	CcSEcCtD
Granisetron—Pain—Betamethasone—hematologic cancer	3.77e-05	0.000135	CcSEcCtD
Granisetron—Pain—Dexamethasone—hematologic cancer	3.77e-05	0.000135	CcSEcCtD
Granisetron—Visual impairment—Doxorubicin—hematologic cancer	3.77e-05	0.000135	CcSEcCtD
Granisetron—Nervous system disorder—Prednisone—hematologic cancer	3.77e-05	0.000135	CcSEcCtD
Granisetron—Tachycardia—Prednisone—hematologic cancer	3.75e-05	0.000135	CcSEcCtD
Granisetron—Alopecia—Epirubicin—hematologic cancer	3.74e-05	0.000134	CcSEcCtD
Granisetron—Skin disorder—Prednisone—hematologic cancer	3.73e-05	0.000134	CcSEcCtD
Granisetron—Nausea—Gemcitabine—hematologic cancer	3.73e-05	0.000134	CcSEcCtD
Granisetron—Vomiting—Cisplatin—hematologic cancer	3.72e-05	0.000134	CcSEcCtD
Granisetron—Hyperhidrosis—Prednisone—hematologic cancer	3.71e-05	0.000133	CcSEcCtD
Granisetron—Rash—Cisplatin—hematologic cancer	3.69e-05	0.000132	CcSEcCtD
Granisetron—Dermatitis—Cisplatin—hematologic cancer	3.69e-05	0.000132	CcSEcCtD
Granisetron—Malnutrition—Epirubicin—hematologic cancer	3.68e-05	0.000132	CcSEcCtD
Granisetron—Diarrhoea—Etoposide—hematologic cancer	3.67e-05	0.000132	CcSEcCtD
Granisetron—Ill-defined disorder—Methotrexate—hematologic cancer	3.65e-05	0.000131	CcSEcCtD
Granisetron—Anaemia—Methotrexate—hematologic cancer	3.64e-05	0.000131	CcSEcCtD
Granisetron—Feeling abnormal—Betamethasone—hematologic cancer	3.64e-05	0.000131	CcSEcCtD
Granisetron—Feeling abnormal—Dexamethasone—hematologic cancer	3.64e-05	0.000131	CcSEcCtD
Granisetron—Flushing—Doxorubicin—hematologic cancer	3.63e-05	0.00013	CcSEcCtD
Granisetron—Flatulence—Epirubicin—hematologic cancer	3.63e-05	0.00013	CcSEcCtD
Granisetron—Tension—Epirubicin—hematologic cancer	3.61e-05	0.00013	CcSEcCtD
Granisetron—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.61e-05	0.00013	CcSEcCtD
Granisetron—Gastrointestinal pain—Betamethasone—hematologic cancer	3.61e-05	0.00013	CcSEcCtD
Granisetron—Dysgeusia—Epirubicin—hematologic cancer	3.61e-05	0.000129	CcSEcCtD
Granisetron—Hypersensitivity—Triamcinolone—hematologic cancer	3.58e-05	0.000129	CcSEcCtD
Granisetron—Nervousness—Epirubicin—hematologic cancer	3.58e-05	0.000128	CcSEcCtD
Granisetron—Angiopathy—Doxorubicin—hematologic cancer	3.55e-05	0.000127	CcSEcCtD
Granisetron—Malaise—Methotrexate—hematologic cancer	3.55e-05	0.000127	CcSEcCtD
Granisetron—Dizziness—Etoposide—hematologic cancer	3.55e-05	0.000127	CcSEcCtD
Granisetron—Vertigo—Methotrexate—hematologic cancer	3.53e-05	0.000127	CcSEcCtD
Granisetron—Leukopenia—Methotrexate—hematologic cancer	3.52e-05	0.000126	CcSEcCtD
Granisetron—Chills—Doxorubicin—hematologic cancer	3.51e-05	0.000126	CcSEcCtD
Granisetron—Urticaria—Betamethasone—hematologic cancer	3.5e-05	0.000126	CcSEcCtD
Granisetron—Urticaria—Dexamethasone—hematologic cancer	3.5e-05	0.000126	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.5e-05	0.000126	CcSEcCtD
Granisetron—Dizziness—Prednisolone—hematologic cancer	3.5e-05	0.000126	CcSEcCtD
Granisetron—Arrhythmia—Doxorubicin—hematologic cancer	3.5e-05	0.000126	CcSEcCtD
Granisetron—Asthenia—Triamcinolone—hematologic cancer	3.49e-05	0.000125	CcSEcCtD
Granisetron—Body temperature increased—Betamethasone—hematologic cancer	3.49e-05	0.000125	CcSEcCtD
Granisetron—Body temperature increased—Dexamethasone—hematologic cancer	3.49e-05	0.000125	CcSEcCtD
Granisetron—Abdominal pain—Betamethasone—hematologic cancer	3.49e-05	0.000125	CcSEcCtD
Granisetron—Abdominal pain—Dexamethasone—hematologic cancer	3.49e-05	0.000125	CcSEcCtD
Granisetron—Nausea—Cisplatin—hematologic cancer	3.48e-05	0.000125	CcSEcCtD
Granisetron—Insomnia—Prednisone—hematologic cancer	3.48e-05	0.000125	CcSEcCtD
Granisetron—Alopecia—Doxorubicin—hematologic cancer	3.46e-05	0.000124	CcSEcCtD
Granisetron—Paraesthesia—Prednisone—hematologic cancer	3.45e-05	0.000124	CcSEcCtD
Granisetron—Pruritus—Triamcinolone—hematologic cancer	3.44e-05	0.000124	CcSEcCtD
Granisetron—Cough—Methotrexate—hematologic cancer	3.43e-05	0.000123	CcSEcCtD
Granisetron—Ill-defined disorder—Epirubicin—hematologic cancer	3.42e-05	0.000123	CcSEcCtD
Granisetron—Vomiting—Etoposide—hematologic cancer	3.41e-05	0.000122	CcSEcCtD
Granisetron—Malnutrition—Doxorubicin—hematologic cancer	3.41e-05	0.000122	CcSEcCtD
Granisetron—Anaemia—Epirubicin—hematologic cancer	3.4e-05	0.000122	CcSEcCtD
Granisetron—Agitation—Epirubicin—hematologic cancer	3.38e-05	0.000121	CcSEcCtD
Granisetron—Dyspepsia—Prednisone—hematologic cancer	3.38e-05	0.000121	CcSEcCtD
Granisetron—Rash—Etoposide—hematologic cancer	3.38e-05	0.000121	CcSEcCtD
Granisetron—Dermatitis—Etoposide—hematologic cancer	3.38e-05	0.000121	CcSEcCtD
Granisetron—Headache—Etoposide—hematologic cancer	3.36e-05	0.000121	CcSEcCtD
Granisetron—Flatulence—Doxorubicin—hematologic cancer	3.36e-05	0.000121	CcSEcCtD
Granisetron—Chest pain—Methotrexate—hematologic cancer	3.35e-05	0.00012	CcSEcCtD
Granisetron—Arthralgia—Methotrexate—hematologic cancer	3.35e-05	0.00012	CcSEcCtD
Granisetron—Tension—Doxorubicin—hematologic cancer	3.34e-05	0.00012	CcSEcCtD
Granisetron—Decreased appetite—Prednisone—hematologic cancer	3.34e-05	0.00012	CcSEcCtD
Granisetron—Dysgeusia—Doxorubicin—hematologic cancer	3.34e-05	0.00012	CcSEcCtD
Granisetron—Rash—Prednisolone—hematologic cancer	3.33e-05	0.00012	CcSEcCtD
Granisetron—Dermatitis—Prednisolone—hematologic cancer	3.33e-05	0.00012	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.33e-05	0.000119	CcSEcCtD
Granisetron—Malaise—Epirubicin—hematologic cancer	3.32e-05	0.000119	CcSEcCtD
Granisetron—Headache—Prednisolone—hematologic cancer	3.31e-05	0.000119	CcSEcCtD
Granisetron—Discomfort—Methotrexate—hematologic cancer	3.31e-05	0.000119	CcSEcCtD
Granisetron—Nervousness—Doxorubicin—hematologic cancer	3.31e-05	0.000119	CcSEcCtD
Granisetron—Vertigo—Epirubicin—hematologic cancer	3.31e-05	0.000119	CcSEcCtD
Granisetron—Syncope—Epirubicin—hematologic cancer	3.3e-05	0.000119	CcSEcCtD
Granisetron—Leukopenia—Epirubicin—hematologic cancer	3.3e-05	0.000118	CcSEcCtD
Granisetron—Constipation—Prednisone—hematologic cancer	3.29e-05	0.000118	CcSEcCtD
Granisetron—Palpitations—Epirubicin—hematologic cancer	3.25e-05	0.000117	CcSEcCtD
Granisetron—Loss of consciousness—Epirubicin—hematologic cancer	3.24e-05	0.000116	CcSEcCtD
Granisetron—Dizziness—Triamcinolone—hematologic cancer	3.22e-05	0.000115	CcSEcCtD
Granisetron—Cough—Epirubicin—hematologic cancer	3.21e-05	0.000115	CcSEcCtD
Granisetron—Anaphylactic shock—Methotrexate—hematologic cancer	3.21e-05	0.000115	CcSEcCtD
Granisetron—Infection—Methotrexate—hematologic cancer	3.19e-05	0.000115	CcSEcCtD
Granisetron—Nausea—Etoposide—hematologic cancer	3.18e-05	0.000114	CcSEcCtD
Granisetron—Hypertension—Epirubicin—hematologic cancer	3.18e-05	0.000114	CcSEcCtD
Granisetron—Feeling abnormal—Prednisone—hematologic cancer	3.17e-05	0.000114	CcSEcCtD
Granisetron—Asthenia—Dexamethasone—hematologic cancer	3.17e-05	0.000114	CcSEcCtD
Granisetron—Asthenia—Betamethasone—hematologic cancer	3.17e-05	0.000114	CcSEcCtD
Granisetron—Ill-defined disorder—Doxorubicin—hematologic cancer	3.16e-05	0.000113	CcSEcCtD
Granisetron—Nervous system disorder—Methotrexate—hematologic cancer	3.15e-05	0.000113	CcSEcCtD
Granisetron—Anaemia—Doxorubicin—hematologic cancer	3.15e-05	0.000113	CcSEcCtD
Granisetron—Thrombocytopenia—Methotrexate—hematologic cancer	3.14e-05	0.000113	CcSEcCtD
Granisetron—Gastrointestinal pain—Prednisone—hematologic cancer	3.14e-05	0.000113	CcSEcCtD
Granisetron—Nausea—Prednisolone—hematologic cancer	3.14e-05	0.000113	CcSEcCtD
Granisetron—Chest pain—Epirubicin—hematologic cancer	3.13e-05	0.000113	CcSEcCtD
Granisetron—Arthralgia—Epirubicin—hematologic cancer	3.13e-05	0.000113	CcSEcCtD
Granisetron—Agitation—Doxorubicin—hematologic cancer	3.13e-05	0.000112	CcSEcCtD
Granisetron—Anxiety—Epirubicin—hematologic cancer	3.12e-05	0.000112	CcSEcCtD
Granisetron—Pruritus—Betamethasone—hematologic cancer	3.12e-05	0.000112	CcSEcCtD
Granisetron—Pruritus—Dexamethasone—hematologic cancer	3.12e-05	0.000112	CcSEcCtD
Granisetron—Skin disorder—Methotrexate—hematologic cancer	3.12e-05	0.000112	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.11e-05	0.000112	CcSEcCtD
Granisetron—Hyperhidrosis—Methotrexate—hematologic cancer	3.1e-05	0.000111	CcSEcCtD
Granisetron—Discomfort—Epirubicin—hematologic cancer	3.1e-05	0.000111	CcSEcCtD
Granisetron—Vomiting—Triamcinolone—hematologic cancer	3.09e-05	0.000111	CcSEcCtD
Granisetron—Malaise—Doxorubicin—hematologic cancer	3.07e-05	0.00011	CcSEcCtD
Granisetron—Rash—Triamcinolone—hematologic cancer	3.07e-05	0.00011	CcSEcCtD
Granisetron—Dry mouth—Epirubicin—hematologic cancer	3.07e-05	0.00011	CcSEcCtD
Granisetron—Dermatitis—Triamcinolone—hematologic cancer	3.06e-05	0.00011	CcSEcCtD
Granisetron—Vertigo—Doxorubicin—hematologic cancer	3.06e-05	0.00011	CcSEcCtD
Granisetron—Syncope—Doxorubicin—hematologic cancer	3.06e-05	0.00011	CcSEcCtD
Granisetron—Urticaria—Prednisone—hematologic cancer	3.05e-05	0.00011	CcSEcCtD
Granisetron—Leukopenia—Doxorubicin—hematologic cancer	3.05e-05	0.000109	CcSEcCtD
Granisetron—Headache—Triamcinolone—hematologic cancer	3.05e-05	0.000109	CcSEcCtD
Granisetron—Abdominal pain—Prednisone—hematologic cancer	3.04e-05	0.000109	CcSEcCtD
Granisetron—Body temperature increased—Prednisone—hematologic cancer	3.04e-05	0.000109	CcSEcCtD
Granisetron—Diarrhoea—Betamethasone—hematologic cancer	3.02e-05	0.000108	CcSEcCtD
Granisetron—Diarrhoea—Dexamethasone—hematologic cancer	3.02e-05	0.000108	CcSEcCtD
Granisetron—Palpitations—Doxorubicin—hematologic cancer	3.01e-05	0.000108	CcSEcCtD
Granisetron—Anaphylactic shock—Epirubicin—hematologic cancer	3.01e-05	0.000108	CcSEcCtD
Granisetron—Oedema—Epirubicin—hematologic cancer	3.01e-05	0.000108	CcSEcCtD
Granisetron—Hypotension—Methotrexate—hematologic cancer	3e-05	0.000108	CcSEcCtD
Granisetron—Loss of consciousness—Doxorubicin—hematologic cancer	2.99e-05	0.000108	CcSEcCtD
Granisetron—Infection—Epirubicin—hematologic cancer	2.99e-05	0.000107	CcSEcCtD
Granisetron—Cough—Doxorubicin—hematologic cancer	2.97e-05	0.000107	CcSEcCtD
Granisetron—Shock—Epirubicin—hematologic cancer	2.96e-05	0.000106	CcSEcCtD
Granisetron—Nervous system disorder—Epirubicin—hematologic cancer	2.95e-05	0.000106	CcSEcCtD
Granisetron—Thrombocytopenia—Epirubicin—hematologic cancer	2.94e-05	0.000106	CcSEcCtD
Granisetron—Hypertension—Doxorubicin—hematologic cancer	2.94e-05	0.000106	CcSEcCtD
Granisetron—Tachycardia—Epirubicin—hematologic cancer	2.93e-05	0.000105	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.93e-05	0.000105	CcSEcCtD
Granisetron—Skin disorder—Epirubicin—hematologic cancer	2.92e-05	0.000105	CcSEcCtD
Granisetron—Dizziness—Dexamethasone—hematologic cancer	2.92e-05	0.000105	CcSEcCtD
Granisetron—Dizziness—Betamethasone—hematologic cancer	2.92e-05	0.000105	CcSEcCtD
Granisetron—Hyperhidrosis—Epirubicin—hematologic cancer	2.91e-05	0.000104	CcSEcCtD
Granisetron—Insomnia—Methotrexate—hematologic cancer	2.9e-05	0.000104	CcSEcCtD
Granisetron—Chest pain—Doxorubicin—hematologic cancer	2.9e-05	0.000104	CcSEcCtD
Granisetron—Arthralgia—Doxorubicin—hematologic cancer	2.9e-05	0.000104	CcSEcCtD
Granisetron—Anxiety—Doxorubicin—hematologic cancer	2.89e-05	0.000104	CcSEcCtD
Granisetron—Nausea—Triamcinolone—hematologic cancer	2.89e-05	0.000104	CcSEcCtD
Granisetron—Paraesthesia—Methotrexate—hematologic cancer	2.88e-05	0.000104	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.88e-05	0.000103	CcSEcCtD
Granisetron—Discomfort—Doxorubicin—hematologic cancer	2.87e-05	0.000103	CcSEcCtD
Granisetron—Dyspnoea—Methotrexate—hematologic cancer	2.86e-05	0.000103	CcSEcCtD
Granisetron—Somnolence—Methotrexate—hematologic cancer	2.85e-05	0.000102	CcSEcCtD
Granisetron—Dry mouth—Doxorubicin—hematologic cancer	2.84e-05	0.000102	CcSEcCtD
Granisetron—Hypersensitivity—Prednisone—hematologic cancer	2.83e-05	0.000102	CcSEcCtD
Granisetron—Dyspepsia—Methotrexate—hematologic cancer	2.83e-05	0.000101	CcSEcCtD
Granisetron—Hypotension—Epirubicin—hematologic cancer	2.81e-05	0.000101	CcSEcCtD
Granisetron—Vomiting—Betamethasone—hematologic cancer	2.81e-05	0.000101	CcSEcCtD
Granisetron—Vomiting—Dexamethasone—hematologic cancer	2.81e-05	0.000101	CcSEcCtD
Granisetron—Decreased appetite—Methotrexate—hematologic cancer	2.79e-05	0.0001	CcSEcCtD
Granisetron—Rash—Betamethasone—hematologic cancer	2.78e-05	9.99e-05	CcSEcCtD
Granisetron—Rash—Dexamethasone—hematologic cancer	2.78e-05	9.99e-05	CcSEcCtD
Granisetron—Oedema—Doxorubicin—hematologic cancer	2.78e-05	9.98e-05	CcSEcCtD
Granisetron—Anaphylactic shock—Doxorubicin—hematologic cancer	2.78e-05	9.98e-05	CcSEcCtD
Granisetron—Dermatitis—Dexamethasone—hematologic cancer	2.78e-05	9.98e-05	CcSEcCtD
Granisetron—Dermatitis—Betamethasone—hematologic cancer	2.78e-05	9.98e-05	CcSEcCtD
Granisetron—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.77e-05	9.95e-05	CcSEcCtD
Granisetron—Headache—Dexamethasone—hematologic cancer	2.76e-05	9.92e-05	CcSEcCtD
Granisetron—Headache—Betamethasone—hematologic cancer	2.76e-05	9.92e-05	CcSEcCtD
Granisetron—Infection—Doxorubicin—hematologic cancer	2.76e-05	9.92e-05	CcSEcCtD
Granisetron—Asthenia—Prednisone—hematologic cancer	2.76e-05	9.9e-05	CcSEcCtD
Granisetron—Pain—Methotrexate—hematologic cancer	2.75e-05	9.86e-05	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.74e-05	9.83e-05	CcSEcCtD
Granisetron—Shock—Doxorubicin—hematologic cancer	2.74e-05	9.82e-05	CcSEcCtD
Granisetron—Nervous system disorder—Doxorubicin—hematologic cancer	2.73e-05	9.79e-05	CcSEcCtD
Granisetron—Thrombocytopenia—Doxorubicin—hematologic cancer	2.72e-05	9.77e-05	CcSEcCtD
Granisetron—Pruritus—Prednisone—hematologic cancer	2.72e-05	9.76e-05	CcSEcCtD
Granisetron—Insomnia—Epirubicin—hematologic cancer	2.72e-05	9.76e-05	CcSEcCtD
Granisetron—Tachycardia—Doxorubicin—hematologic cancer	2.71e-05	9.74e-05	CcSEcCtD
Granisetron—Skin disorder—Doxorubicin—hematologic cancer	2.7e-05	9.7e-05	CcSEcCtD
Granisetron—Paraesthesia—Epirubicin—hematologic cancer	2.7e-05	9.69e-05	CcSEcCtD
Granisetron—Hyperhidrosis—Doxorubicin—hematologic cancer	2.69e-05	9.65e-05	CcSEcCtD
Granisetron—Dyspnoea—Epirubicin—hematologic cancer	2.68e-05	9.62e-05	CcSEcCtD
Granisetron—Somnolence—Epirubicin—hematologic cancer	2.67e-05	9.59e-05	CcSEcCtD
Granisetron—Feeling abnormal—Methotrexate—hematologic cancer	2.65e-05	9.5e-05	CcSEcCtD
Granisetron—Dyspepsia—Epirubicin—hematologic cancer	2.65e-05	9.5e-05	CcSEcCtD
Granisetron—Diarrhoea—Prednisone—hematologic cancer	2.63e-05	9.44e-05	CcSEcCtD
Granisetron—Gastrointestinal pain—Methotrexate—hematologic cancer	2.63e-05	9.43e-05	CcSEcCtD
Granisetron—Nausea—Dexamethasone—hematologic cancer	2.62e-05	9.41e-05	CcSEcCtD
Granisetron—Nausea—Betamethasone—hematologic cancer	2.62e-05	9.41e-05	CcSEcCtD
Granisetron—Decreased appetite—Epirubicin—hematologic cancer	2.61e-05	9.38e-05	CcSEcCtD
Granisetron—Hypotension—Doxorubicin—hematologic cancer	2.6e-05	9.33e-05	CcSEcCtD
Granisetron—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.59e-05	9.31e-05	CcSEcCtD
Granisetron—Constipation—Epirubicin—hematologic cancer	2.57e-05	9.23e-05	CcSEcCtD
Granisetron—Pain—Epirubicin—hematologic cancer	2.57e-05	9.23e-05	CcSEcCtD
Granisetron—Urticaria—Methotrexate—hematologic cancer	2.55e-05	9.16e-05	CcSEcCtD
Granisetron—Dizziness—Prednisone—hematologic cancer	2.54e-05	9.12e-05	CcSEcCtD
Granisetron—Body temperature increased—Methotrexate—hematologic cancer	2.54e-05	9.11e-05	CcSEcCtD
Granisetron—Abdominal pain—Methotrexate—hematologic cancer	2.54e-05	9.11e-05	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.53e-05	9.09e-05	CcSEcCtD
Granisetron—Insomnia—Doxorubicin—hematologic cancer	2.51e-05	9.03e-05	CcSEcCtD
Granisetron—Paraesthesia—Doxorubicin—hematologic cancer	2.5e-05	8.96e-05	CcSEcCtD
Granisetron—Dyspnoea—Doxorubicin—hematologic cancer	2.48e-05	8.9e-05	CcSEcCtD
Granisetron—Feeling abnormal—Epirubicin—hematologic cancer	2.48e-05	8.89e-05	CcSEcCtD
Granisetron—Somnolence—Doxorubicin—hematologic cancer	2.47e-05	8.87e-05	CcSEcCtD
Granisetron—Gastrointestinal pain—Epirubicin—hematologic cancer	2.46e-05	8.82e-05	CcSEcCtD
Granisetron—CYP1A1—Metabolism—SMPD3—hematologic cancer	2.45e-05	0.000717	CbGpPWpGaD
Granisetron—Dyspepsia—Doxorubicin—hematologic cancer	2.45e-05	8.79e-05	CcSEcCtD
Granisetron—Vomiting—Prednisone—hematologic cancer	2.44e-05	8.77e-05	CcSEcCtD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.44e-05	0.000716	CbGpPWpGaD
Granisetron—Rash—Prednisone—hematologic cancer	2.42e-05	8.7e-05	CcSEcCtD
Granisetron—Dermatitis—Prednisone—hematologic cancer	2.42e-05	8.69e-05	CcSEcCtD
Granisetron—Decreased appetite—Doxorubicin—hematologic cancer	2.42e-05	8.68e-05	CcSEcCtD
Granisetron—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	2.42e-05	0.000708	CbGpPWpGaD
Granisetron—Headache—Prednisone—hematologic cancer	2.41e-05	8.64e-05	CcSEcCtD
Granisetron—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.4e-05	8.62e-05	CcSEcCtD
Granisetron—Urticaria—Epirubicin—hematologic cancer	2.39e-05	8.57e-05	CcSEcCtD
Granisetron—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	2.38e-05	0.000698	CbGpPWpGaD
Granisetron—Constipation—Doxorubicin—hematologic cancer	2.38e-05	8.54e-05	CcSEcCtD
Granisetron—Pain—Doxorubicin—hematologic cancer	2.38e-05	8.54e-05	CcSEcCtD
Granisetron—Abdominal pain—Epirubicin—hematologic cancer	2.38e-05	8.53e-05	CcSEcCtD
Granisetron—Body temperature increased—Epirubicin—hematologic cancer	2.38e-05	8.53e-05	CcSEcCtD
Granisetron—Hypersensitivity—Methotrexate—hematologic cancer	2.37e-05	8.49e-05	CcSEcCtD
Granisetron—Asthenia—Methotrexate—hematologic cancer	2.3e-05	8.27e-05	CcSEcCtD
Granisetron—Feeling abnormal—Doxorubicin—hematologic cancer	2.29e-05	8.23e-05	CcSEcCtD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.28e-05	0.000669	CbGpPWpGaD
Granisetron—Nausea—Prednisone—hematologic cancer	2.28e-05	8.19e-05	CcSEcCtD
Granisetron—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.27e-05	8.16e-05	CcSEcCtD
Granisetron—Pruritus—Methotrexate—hematologic cancer	2.27e-05	8.16e-05	CcSEcCtD
Granisetron—CYP3A5—Metabolism—DCK—hematologic cancer	2.26e-05	0.000664	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ASNS—hematologic cancer	2.26e-05	0.000664	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—B3GAT1—hematologic cancer	2.26e-05	0.000664	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.22e-05	0.000652	CbGpPWpGaD
Granisetron—Hypersensitivity—Epirubicin—hematologic cancer	2.21e-05	7.95e-05	CcSEcCtD
Granisetron—Urticaria—Doxorubicin—hematologic cancer	2.21e-05	7.93e-05	CcSEcCtD
Granisetron—Body temperature increased—Doxorubicin—hematologic cancer	2.2e-05	7.89e-05	CcSEcCtD
Granisetron—Abdominal pain—Doxorubicin—hematologic cancer	2.2e-05	7.89e-05	CcSEcCtD
Granisetron—Diarrhoea—Methotrexate—hematologic cancer	2.2e-05	7.89e-05	CcSEcCtD
Granisetron—Asthenia—Epirubicin—hematologic cancer	2.16e-05	7.74e-05	CcSEcCtD
Granisetron—CYP1A1—PPARA activates gene expression—EP300—hematologic cancer	2.15e-05	0.000631	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HDC—hematologic cancer	2.15e-05	0.000629	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—B3GAT1—hematologic cancer	2.14e-05	0.000627	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—DCK—hematologic cancer	2.14e-05	0.000627	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ASNS—hematologic cancer	2.14e-05	0.000627	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—hematologic cancer	2.13e-05	0.000624	CbGpPWpGaD
Granisetron—Pruritus—Epirubicin—hematologic cancer	2.13e-05	7.63e-05	CcSEcCtD
Granisetron—Dizziness—Methotrexate—hematologic cancer	2.12e-05	7.62e-05	CcSEcCtD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—hematologic cancer	2.11e-05	0.000617	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.09e-05	0.000613	CbGpPWpGaD
Granisetron—Diarrhoea—Epirubicin—hematologic cancer	2.06e-05	7.38e-05	CcSEcCtD
Granisetron—Hypersensitivity—Doxorubicin—hematologic cancer	2.05e-05	7.35e-05	CcSEcCtD
Granisetron—Vomiting—Methotrexate—hematologic cancer	2.04e-05	7.33e-05	CcSEcCtD
Granisetron—CYP1A1—Metabolism—HDC—hematologic cancer	2.03e-05	0.000594	CbGpPWpGaD
Granisetron—Rash—Methotrexate—hematologic cancer	2.02e-05	7.27e-05	CcSEcCtD
Granisetron—Dermatitis—Methotrexate—hematologic cancer	2.02e-05	7.26e-05	CcSEcCtD
Granisetron—CYP2D6—Metabolism—GMPS—hematologic cancer	2.01e-05	0.00059	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PHYH—hematologic cancer	2.01e-05	0.00059	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—FTCD—hematologic cancer	2.01e-05	0.00059	CbGpPWpGaD
Granisetron—Headache—Methotrexate—hematologic cancer	2.01e-05	7.22e-05	CcSEcCtD
Granisetron—Asthenia—Doxorubicin—hematologic cancer	1.99e-05	7.16e-05	CcSEcCtD
Granisetron—Dizziness—Epirubicin—hematologic cancer	1.99e-05	7.13e-05	CcSEcCtD
Granisetron—Pruritus—Doxorubicin—hematologic cancer	1.97e-05	7.06e-05	CcSEcCtD
Granisetron—CYP3A5—Metabolism—CDA—hematologic cancer	1.96e-05	0.000575	CbGpPWpGaD
Granisetron—Vomiting—Epirubicin—hematologic cancer	1.91e-05	6.86e-05	CcSEcCtD
Granisetron—Nausea—Methotrexate—hematologic cancer	1.91e-05	6.85e-05	CcSEcCtD
Granisetron—Diarrhoea—Doxorubicin—hematologic cancer	1.9e-05	6.83e-05	CcSEcCtD
Granisetron—Rash—Epirubicin—hematologic cancer	1.89e-05	6.8e-05	CcSEcCtD
Granisetron—Dermatitis—Epirubicin—hematologic cancer	1.89e-05	6.8e-05	CcSEcCtD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.89e-05	0.000554	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PC—hematologic cancer	1.89e-05	0.000554	CbGpPWpGaD
Granisetron—Headache—Epirubicin—hematologic cancer	1.88e-05	6.76e-05	CcSEcCtD
Granisetron—CYP1A1—Metabolism—CDA—hematologic cancer	1.86e-05	0.000544	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SMPD3—hematologic cancer	1.84e-05	0.00054	CbGpPWpGaD
Granisetron—Dizziness—Doxorubicin—hematologic cancer	1.84e-05	6.6e-05	CcSEcCtD
Granisetron—CYP3A5—Metabolism—SLC35B2—hematologic cancer	1.83e-05	0.000535	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GBA—hematologic cancer	1.83e-05	0.000535	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PC—hematologic cancer	1.79e-05	0.000523	CbGpPWpGaD
Granisetron—Nausea—Epirubicin—hematologic cancer	1.78e-05	6.41e-05	CcSEcCtD
Granisetron—Vomiting—Doxorubicin—hematologic cancer	1.77e-05	6.35e-05	CcSEcCtD
Granisetron—Rash—Doxorubicin—hematologic cancer	1.75e-05	6.29e-05	CcSEcCtD
Granisetron—Dermatitis—Doxorubicin—hematologic cancer	1.75e-05	6.29e-05	CcSEcCtD
Granisetron—Headache—Doxorubicin—hematologic cancer	1.74e-05	6.25e-05	CcSEcCtD
Granisetron—CYP1A1—Metabolism—GBA—hematologic cancer	1.72e-05	0.000505	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC35B2—hematologic cancer	1.72e-05	0.000505	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.72e-05	0.000504	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.7e-05	0.000497	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—MTAP—hematologic cancer	1.67e-05	0.000489	CbGpPWpGaD
Granisetron—Nausea—Doxorubicin—hematologic cancer	1.65e-05	5.93e-05	CcSEcCtD
Granisetron—CYP2D6—Metabolism—B3GAT1—hematologic cancer	1.61e-05	0.000472	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—DCK—hematologic cancer	1.61e-05	0.000472	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ASNS—hematologic cancer	1.61e-05	0.000472	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.58e-05	0.000463	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—MTAP—hematologic cancer	1.58e-05	0.000462	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.56e-05	0.000456	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HDC—hematologic cancer	1.53e-05	0.000447	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—FHL2—hematologic cancer	1.49e-05	0.000436	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—AGRN—hematologic cancer	1.46e-05	0.000428	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—hematologic cancer	1.45e-05	0.000425	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—FHL2—hematologic cancer	1.41e-05	0.000412	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CDA—hematologic cancer	1.4e-05	0.000409	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—IDH2—hematologic cancer	1.38e-05	0.000405	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HMMR—hematologic cancer	1.38e-05	0.000405	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—AGRN—hematologic cancer	1.38e-05	0.000404	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PC—hematologic cancer	1.34e-05	0.000394	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PHYH—hematologic cancer	1.32e-05	0.000386	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GMPS—hematologic cancer	1.32e-05	0.000386	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—FTCD—hematologic cancer	1.32e-05	0.000386	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—IDH2—hematologic cancer	1.31e-05	0.000383	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—HMMR—hematologic cancer	1.31e-05	0.000383	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ARNTL—hematologic cancer	1.3e-05	0.000381	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GBA—hematologic cancer	1.3e-05	0.00038	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.3e-05	0.00038	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CA9—hematologic cancer	1.27e-05	0.000371	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ACP5—hematologic cancer	1.27e-05	0.000371	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NCOR2—hematologic cancer	1.25e-05	0.000366	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.23e-05	0.000361	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ARNTL—hematologic cancer	1.23e-05	0.00036	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.2e-05	0.000353	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CA9—hematologic cancer	1.2e-05	0.00035	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ACP5—hematologic cancer	1.2e-05	0.00035	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—IDH1—hematologic cancer	1.19e-05	0.000349	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—MTAP—hematologic cancer	1.19e-05	0.000348	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NCOR2—hematologic cancer	1.18e-05	0.000346	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ABCC3—hematologic cancer	1.18e-05	0.000345	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—TXN—hematologic cancer	1.18e-05	0.000345	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTO1—hematologic cancer	1.18e-05	0.000345	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SPHK1—hematologic cancer	1.15e-05	0.000337	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—IDH1—hematologic cancer	1.12e-05	0.000329	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ABCC3—hematologic cancer	1.11e-05	0.000326	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—TXN—hematologic cancer	1.11e-05	0.000326	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTO1—hematologic cancer	1.11e-05	0.000326	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—UGT1A1—hematologic cancer	1.11e-05	0.000324	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SPHK1—hematologic cancer	1.09e-05	0.000319	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SLC22A1—hematologic cancer	1.08e-05	0.000315	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CRABP1—hematologic cancer	1.08e-05	0.000315	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—FHL2—hematologic cancer	1.06e-05	0.00031	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.05e-05	0.000309	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—DCK—hematologic cancer	1.05e-05	0.000309	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ASNS—hematologic cancer	1.05e-05	0.000309	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ALOX5—hematologic cancer	1.05e-05	0.000307	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—UGT1A1—hematologic cancer	1.04e-05	0.000306	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—AGRN—hematologic cancer	1.04e-05	0.000304	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC22A1—hematologic cancer	1.02e-05	0.000298	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CRABP1—hematologic cancer	1.02e-05	0.000298	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NUP98—hematologic cancer	1.02e-05	0.000298	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HDC—hematologic cancer	9.98e-06	0.000292	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ALOX5—hematologic cancer	9.91e-06	0.00029	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ADCY7—hematologic cancer	9.86e-06	0.000289	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NCOA3—hematologic cancer	9.86e-06	0.000289	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HMMR—hematologic cancer	9.84e-06	0.000288	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—IDH2—hematologic cancer	9.84e-06	0.000288	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NUP214—hematologic cancer	9.79e-06	0.000287	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NUP98—hematologic cancer	9.59e-06	0.000281	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ABCG2—hematologic cancer	9.59e-06	0.000281	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—MTR—hematologic cancer	9.59e-06	0.000281	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ENO2—hematologic cancer	9.4e-06	0.000276	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NCOA3—hematologic cancer	9.31e-06	0.000273	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ADCY7—hematologic cancer	9.31e-06	0.000273	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ARNTL—hematologic cancer	9.25e-06	0.000271	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NUP214—hematologic cancer	9.25e-06	0.000271	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.15e-06	0.000268	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CDA—hematologic cancer	9.13e-06	0.000267	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTT1—hematologic cancer	9.12e-06	0.000267	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ABCG2—hematologic cancer	9.06e-06	0.000265	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—MTR—hematologic cancer	9.06e-06	0.000265	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CA9—hematologic cancer	9e-06	0.000264	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ACP5—hematologic cancer	9e-06	0.000264	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SDC1—hematologic cancer	8.91e-06	0.000261	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ENO2—hematologic cancer	8.88e-06	0.00026	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NCOR2—hematologic cancer	8.88e-06	0.00026	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PC—hematologic cancer	8.79e-06	0.000257	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTT1—hematologic cancer	8.62e-06	0.000252	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GBA—hematologic cancer	8.49e-06	0.000249	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC35B2—hematologic cancer	8.49e-06	0.000249	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.49e-06	0.000249	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—IDH1—hematologic cancer	8.46e-06	0.000248	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SDC1—hematologic cancer	8.42e-06	0.000247	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—TXN—hematologic cancer	8.36e-06	0.000245	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ABCC3—hematologic cancer	8.36e-06	0.000245	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTO1—hematologic cancer	8.36e-06	0.000245	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SPHK1—hematologic cancer	8.19e-06	0.00024	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.05e-06	0.000236	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.94e-06	0.000233	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—UGT1A1—hematologic cancer	7.86e-06	0.00023	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—MTAP—hematologic cancer	7.76e-06	0.000227	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CRABP1—hematologic cancer	7.65e-06	0.000224	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC22A1—hematologic cancer	7.65e-06	0.000224	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.6e-06	0.000223	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CD44—hematologic cancer	7.58e-06	0.000222	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NQO1—hematologic cancer	7.58e-06	0.000222	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ALOX5—hematologic cancer	7.46e-06	0.000218	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NUP98—hematologic cancer	7.22e-06	0.000212	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYCS—hematologic cancer	7.17e-06	0.00021	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CD44—hematologic cancer	7.16e-06	0.00021	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NQO1—hematologic cancer	7.16e-06	0.00021	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	7.13e-06	0.000209	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.01e-06	0.000205	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ADCY7—hematologic cancer	7.01e-06	0.000205	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NCOA3—hematologic cancer	7.01e-06	0.000205	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NUP214—hematologic cancer	6.96e-06	0.000204	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—FHL2—hematologic cancer	6.92e-06	0.000203	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—MTR—hematologic cancer	6.82e-06	0.0002	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ABCG2—hematologic cancer	6.82e-06	0.0002	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—AGRN—hematologic cancer	6.78e-06	0.000199	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYCS—hematologic cancer	6.78e-06	0.000199	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	6.73e-06	0.000197	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ENO2—hematologic cancer	6.69e-06	0.000196	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTT1—hematologic cancer	6.49e-06	0.00019	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—IDH2—hematologic cancer	6.43e-06	0.000188	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HMMR—hematologic cancer	6.43e-06	0.000188	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SDC1—hematologic cancer	6.34e-06	0.000186	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTP1—hematologic cancer	6.32e-06	0.000185	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.06e-06	0.000178	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.05e-06	0.000177	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ABCB1—hematologic cancer	5.98e-06	0.000175	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTP1—hematologic cancer	5.97e-06	0.000175	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ACP5—hematologic cancer	5.88e-06	0.000172	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CA9—hematologic cancer	5.88e-06	0.000172	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NCOR1—hematologic cancer	5.81e-06	0.00017	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTM1—hematologic cancer	5.81e-06	0.00017	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.81e-06	0.00017	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.78e-06	0.000169	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ABCB1—hematologic cancer	5.65e-06	0.000166	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—IDH1—hematologic cancer	5.53e-06	0.000162	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NCOR1—hematologic cancer	5.49e-06	0.000161	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTM1—hematologic cancer	5.49e-06	0.000161	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.47e-06	0.00016	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—TXN—hematologic cancer	5.47e-06	0.00016	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.47e-06	0.00016	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NQO1—hematologic cancer	5.39e-06	0.000158	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CD44—hematologic cancer	5.39e-06	0.000158	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.35e-06	0.000157	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.14e-06	0.000151	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—MTHFR—hematologic cancer	5.13e-06	0.00015	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYCS—hematologic cancer	5.1e-06	0.000149	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.07e-06	0.000148	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5e-06	0.000147	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CRABP1—hematologic cancer	5e-06	0.000147	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.87e-06	0.000143	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—MTHFR—hematologic cancer	4.85e-06	0.000142	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NUP98—hematologic cancer	4.72e-06	0.000138	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.58e-06	0.000134	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.58e-06	0.000134	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NUP214—hematologic cancer	4.55e-06	0.000133	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.5e-06	0.000132	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.46e-06	0.000131	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—MTR—hematologic cancer	4.46e-06	0.000131	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ENO2—hematologic cancer	4.37e-06	0.000128	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CG—hematologic cancer	4.31e-06	0.000126	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.27e-06	0.000125	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.26e-06	0.000125	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.24e-06	0.000124	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SDC1—hematologic cancer	4.14e-06	0.000121	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.13e-06	0.000121	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.13e-06	0.000121	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CG—hematologic cancer	4.08e-06	0.000119	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CREBBP—hematologic cancer	4e-06	0.000117	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CD—hematologic cancer	3.79e-06	0.000111	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CREBBP—hematologic cancer	3.78e-06	0.000111	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ALB—hematologic cancer	3.74e-06	0.00011	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.65e-06	0.000107	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CD—hematologic cancer	3.58e-06	0.000105	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3R1—hematologic cancer	3.58e-06	0.000105	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ALB—hematologic cancer	3.54e-06	0.000104	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CD44—hematologic cancer	3.52e-06	0.000103	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NQO1—hematologic cancer	3.52e-06	0.000103	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3R1—hematologic cancer	3.38e-06	9.91e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYCS—hematologic cancer	3.33e-06	9.77e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.31e-06	9.71e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CB—hematologic cancer	3.31e-06	9.69e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CB—hematologic cancer	3.12e-06	9.15e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.07e-06	8.99e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.94e-06	8.61e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTEN—hematologic cancer	2.86e-06	8.37e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.84e-06	8.33e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.78e-06	8.15e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—EP300—hematologic cancer	2.72e-06	7.98e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.7e-06	7.91e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.7e-06	7.91e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTEN—hematologic cancer	2.7e-06	7.91e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.7e-06	7.9e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ALB—hematologic cancer	2.66e-06	7.8e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—EP300—hematologic cancer	2.57e-06	7.54e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.55e-06	7.46e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.39e-06	6.99e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.35e-06	6.89e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTEN—hematologic cancer	2.03e-06	5.95e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.02e-06	5.9e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.01e-06	5.88e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—EP300—hematologic cancer	1.94e-06	5.68e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.9e-06	5.58e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.86e-06	5.45e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.76e-06	5.17e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ALB—hematologic cancer	1.74e-06	5.1e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.66e-06	4.88e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—AKT1—hematologic cancer	1.65e-06	4.82e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—AKT1—hematologic cancer	1.56e-06	4.56e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.54e-06	4.5e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.43e-06	4.2e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTEN—hematologic cancer	1.33e-06	3.89e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—EP300—hematologic cancer	1.27e-06	3.71e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—AKT1—hematologic cancer	1.17e-06	3.43e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.37e-07	2.75e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—AKT1—hematologic cancer	7.65e-07	2.24e-05	CbGpPWpGaD
